SC Filed 2023-03-17 Event — SEC 0000947871-23-000335 →

OrbiMed Israel BioFund GP Limited Partnership → BiomX Inc. PHGE

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

13 filings by this filer

12 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 1.00

190,323 shares short · -79.5% vs prior

Other 13D/G Filings on BiomX Inc.

Filed	Form	Filer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	Flynn James E	4.70%	266,424	view →
2026-05-28	SCHEDULE 13D/A	Flynn James E	8.09%	444,703	view →
2026-04-10	SCHEDULE 13D	T3 Defense Inc.	19.87%	1,300,000	view →
2025-03-03	SCHEDULE	Flynn James E	9.99%	15,558,445	view →
2024-07-11	SC	Flynn James E	—	—	view →
2024-05-30	SC	Flynn James E	—	—	view →

Other Filings by OrbiMed Israel BioFund GP Limited Partnership

Filed	Form	Issuer	Stake	Shares
2024-03-11	SC	Chemomab Therapeutics Ltd. CMMB	—	—	view →
2022-07-01	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2021-06-28	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2021-04-07	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2021-03-25	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2021-01-05	SC	Eledon Pharmaceuticals, Inc. ELDN	—	—	view →
2020-12-16	SC	9 METERS BIOPHARMA, INC.	—	—	view →
2020-11-20	SC	Novus Therapeutics, Inc. ELDN	—	—	view →
2020-10-14	SC	Novus Therapeutics, Inc. ELDN	—	—	view →
2020-02-25	SC	Novus Therapeutics, Inc. ELDN	—	—	view →
2019-05-06	SC	Novus Therapeutics, Inc. ELDN	—	—	view →
2018-03-19	SC	Novus Therapeutics, Inc. ELDN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →